Health Condition 1: O- Medical and Surgical Health Condition 2: H338- Other retinal detachments
Conditions
Interventions
Intervention1: Prednisolone Eye Drops (1%)
: Prednisolone Eye Drops (1%)- 4 Times a
day for duration of 3 weeks.
Intervention2: Dorzolamide Eye Drops (2%): Dorzolamide Eye Drops (2%)-3 Times a d
Sponsors
Hyderabad Eye Research Foundation
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 to 70 years 2. All cases of rhegmatogenous retinal detachments which undergo pars-plana vitrectomy using 23 g vitrectomy system. 3. Follow up for 6 months following cataract surgery. 4. Only cases with Silicone oil tamponade/ SF6 injection will be taken to facilitate the post-operative OCT in follow up.
Exclusion criteria
Exclusion criteria: 1. Patients with retinal vascular disorders 2. Patients with uveitis 3. Patients with myopic retinoschisis 4. Patients with AMD or PCV or other macular conditions unrelated to retinal detachment. 5. With co-existing retinal dystrophies 6. Case with combined retinal detachment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the incidence and risk factors of the cystoid macular edema post vitrectomy for rhegmatogenous retinal detachmentTimepoint: Post-operative 3 weeks, 3 months and 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| INCIDENCE OF ER POST PPV IN RD STimepoint: 3 MONTHS | — |
Countries
India
Contacts
Public ContactMohammed Hasibur Rahman
L V Prasad Eye Institute
Outcome results
None listed